So pharmaceutical giant Merck is no longer in talks to buy Revolution Medicines for over $20 billion.
The venerable Financial Times is on a bit of a hot streak.
Deal hacks at Wall Street Journal must have today been on a similar emotional rollercoaster ride to little old Betaville whilst watching tonight's Chelsea versus Fulham game.